KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Net Income: 2009-2025

Historic Net Income for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $55.6 million.

  • Charles River Laboratories International's Net Income fell 20.97% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$79.6 million, marking a year-over-year decrease of 118.60%. This contributed to the annual value of $25.3 million for FY2024, which is 94.74% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Net Income stood at $55.6 million, which was up 5.43% from $52.7 million recorded in Q2 2025.
  • Charles River Laboratories International's Net Income's 5-year high stood at $189.1 million during Q4 2022, with a 5-year trough of -$213.7 million in Q4 2024.
  • Over the past 3 years, Charles River Laboratories International's median Net Income value was $74.5 million (recorded in 2024), while the average stood at $58.2 million.
  • Per our database at Business Quant, Charles River Laboratories International's Net Income spiked by 48.94% in 2022 and then crashed by 213.12% in 2024.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Net Income stood at $139.8 million in 2021, then soared by 35.24% to $189.1 million in 2022, then fell by 0.08% to $189.0 million in 2023, then slumped by 213.12% to -$213.7 million in 2024, then declined by 20.97% to $55.6 million in 2025.
  • Its last three reported values are $55.6 million in Q3 2025, $52.7 million for Q2 2025, and $25.9 million during Q1 2025.